Andreas Gerward Represents Stayble Therapeutics at NLSDays, Sharing Developments in Life Science | Andreas Gerward, CEO, Stayble Therapeutic AB. 00:10:00
Andreas has during the last 10 years worked with pharmaceutical development in smaller companies. Since joining Stayble as the CEO in 2014 Andreas has developed the company from selection of the candidate drug through preclinical development and successful clinical trials. Andreas has an engineering background and a master’s in economics and Venture Creation from Chalmers University of Technology.
